user

ECONOMIC IMPACT OF TRANSFORMATION TO ACUTE MYELOID LEUKEMIA (AML) AMONG PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HIGHER-RISK MDS) IN THE UNITED STATES: RETROSPECTIVE MATCHED COHORT STUDY

被引：0
|
作者：
Kota, V. [1 ]
Ogbonnaya, A. [2 ]
Farrelly, E. [2 ]
Schroader, B. Kanz [2 ]
Kristo, F. [3 ]
Raju, A. [2 ]
Dalal, M. [3 ]
机构：
[1] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA
[2] Xcenda LLC Real World Evidence, Carrollton, GA USA
[3] Millennium Pharmaceut Inc, wholly Owned Subsidiary Takeda Pharmaceut Co Ltd, Oncol, Cambridge, MA USA
来源：
LEUKEMIA RESEARCH | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P11
引用
收藏
页码：S26 / S27
页数：2
相关论文
共 50 条
  • [1] Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States
    Kota, Vamsi
    Ogbonnaya, Augustina
    Farrelly, Eileen
    Schroader, Bridgette Kanz
    Raju, Aditya
    Kristo, Fjoralba
    Dalal, Mehul
    [J]. ADVANCES IN THERAPY, 2023, 40 (04) : 1655 - 1669
  • [2] Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States
    Vamsi Kota
    Augustina Ogbonnaya
    Eileen Farrelly
    Bridgette Kanz Schroader
    Aditya Raju
    Fjoralba Kristo
    Mehul Dalal
    [J]. Advances in Therapy, 2023, 40 (4) : 1655 - 1669
  • [3] Clinical impact of transformation to acute myeloid leukemia in patients with higher-risk myelodysplastic syndromes
    Kota, Vamsi
    Ogbonnaya, Augustina
    Farrelly, Eileen
    Schroader, Bridgette Kanz
    Raju, Aditya
    Kristo, Fjoralba
    Dalal, Mehul
    [J]. FUTURE ONCOLOGY, 2022, 18 (36) : 4017 - 4029
  • [4] Impact of Transformation to Acute Myeloid Leukemia (AML) on Overall Survival (OS) among Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS) in the United States of America (USA)
    Kota, Vamsi
    Ogbonnaya, Augustina
    Farrelly, Eileen
    Schroader, Bridgette
    Kristo, Fjoralba
    Raju, Aditya
    Dalal, Mehul
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S348 - S348
  • [5] The Safety and Tolerability of Azacitidine (AZA) Are Comparable in Patients with Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndromes (MDS)
    Seymour, John F.
    Silverman, Lewis R.
    Doehner, Hartmut
    Fenaux, Pierre
    Mufti, Ghulam J.
    Santini, Valeria
    Minden, Mark D.
    Stone, Richard M.
    Lucy, Lela M.
    Songer, Stephen
    Dougherty, Donna
    Hinkle, Randy
    Gambini, Dominique
    Beach, C. L.
    Dombret, Herve
    [J]. BLOOD, 2015, 126 (23)
  • [6] Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States
    Jill A. Bell
    Aaron Galaznik
    Marlo Blazer
    Huai-Che Shih
    Eileen Farrelly
    Augustina Ogbonnaya
    Michael Eaddy
    Robert J. Fram
    Douglas V. Faller
    [J]. PharmacoEconomics - Open, 2019, 3 : 237 - 245
  • [7] Immune and Epigenetic Landscape of TP53-mutated Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS)
    Zeidan, Amer M.
    Philipp, Jan
    Bewersdorf, Philipp
    Hasle, Vanessa
    Thompson, Ethan G.
    de Menezes, Daniel Lopes
    Rose, Shelonitda
    Boss, Isaac
    Fox, Brian
    [J]. BLOOD, 2021, 138
  • [8] Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States
    Bell, Jill A.
    Galaznik, Aaron
    Blazer, Mario
    Shih, Huai-Che
    Farrelly, Eileen
    Ogbonnaya, Augustina
    Eaddy, Michael
    Fram, Robert J.
    Faller, Douglas, V
    [J]. PHARMACOECONOMICS-OPEN, 2019, 3 (02) : 237 - 245
  • [9] Decitabine treatment of patients with higher-risk myelodysplastic syndromes
    Steensma, David P.
    [J]. LEUKEMIA RESEARCH, 2009, 33 : S12 - S17
  • [10] Magrolimab Alters the Tumor Microenvironment to Improve Bone Marrow Functions in Patients With Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS)
    Johnson, Lisa
    Zhang, Yajia
    Su-Feher, Linda
    Lee, Yeonju
    Sallman, David A.
    Asch, Adam S.
    Al Malki, Monzr M.
    Kim, Hyunjae Ryan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S368 - S369
12345